{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:27:17Z","timestamp":1787761637901,"version":"build-2784847793"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"977","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Desmopressin is an analog of vasopressin that exerts a substantial haemostatic effect by inducing the release of von Willebrand factor from its storage sites in endothelial cells. It has proved useful in treating or preventing bleeding episodes in patients with von Willebrand disease, haemophilia A and platelet function defects. Its efficacy in achieving a satisfactory level of haemostasis has reduced the use of blood products to treat bleeding episodes. Clinicians need to become familiar with the use of this drug that has become a home medication for many patients with inherited bleeding disorders.<\/jats:p>","DOI":"10.1136\/pgmj.2006.052118","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T01:08:40Z","timestamp":1173316120000},"page":"159-163","source":"Crossref","is-referenced-by-count":70,"title":["How do you treat bleeding disorders with desmopressin?"],"prefix":"10.1093","volume":"83","author":[{"given":"B\u00fclent","family":"\u00d6zg\u00f6nenel","sequence":"first","affiliation":[{"name":"Carman and Ann Adam's Department of Pediatrics, Division of Hematology\/Oncology, Children's Hospital of Michigan, Wayne State University , Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhvi","family":"Rajpurkar","sequence":"additional","affiliation":[{"name":"Carman and Ann Adam's Department of Pediatrics, Division of Hematology\/Oncology, Children's Hospital of Michigan, Wayne State University , Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne M","family":"Lusher","sequence":"additional","affiliation":[{"name":"Carman and Ann Adam's Department of Pediatrics, Division of Hematology\/Oncology, Children's Hospital of Michigan, Wayne State University , Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,3,7]]},"reference":[{"key":"2023042012580118700_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic drugs","volume":"339","author":"Mannucci","year":"1998","journal-title":"N Engl J Med"},{"key":"2023042012580118700_bib2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3476(83)80526-5","article-title":"DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease","volume":"102","author":"Warrier","year":"1983","journal-title":"J Pediatr"},{"key":"2023042012580118700_bib3","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years","volume":"90","author":"Mannucci","year":"1997","journal-title":"Blood"},{"key":"2023042012580118700_bib4","first-page":"1813","volume-title":"Williams hematology","author":"Ginsburg","year":"2001","edition":"6th edn"},{"key":"2023042012580118700_bib5","first-page":"94","article-title":"Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment","volume":"88","author":"Castaman","year":"2003","journal-title":"Haematologica"},{"key":"2023042012580118700_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2004-10-4097","article-title":"ADAMTS13 turns 3","volume":"106","author":"Levy","year":"2005","journal-title":"Blood"},{"key":"2023042012580118700_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000181810","article-title":"Vasopressin agonists and antagonists","volume":"34","author":"Thibonnier","year":"1990","journal-title":"Horm Res"},{"key":"2023042012580118700_bib8","first-page":"528","volume-title":"Disorders of hemostasis & thrombosis: a clinical guide","author":"Scott","year":"2001","edition":"2nd edn"},{"key":"2023042012580118700_bib9","first-page":"276","article-title":"Response to 1-deamino-8-D-arginine vasopressin in von Willebrand disease","volume":"24","author":"Lusher","year":"1994","journal-title":"Haemostasis"},{"key":"2023042012580118700_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand's disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Engl J Med"},{"key":"2023042012580118700_bib11","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2003-06-2072","article-title":"Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study","volume":"103","author":"Federici","year":"2004","journal-title":"Blood"},{"key":"2023042012580118700_bib12","first-page":"1850","volume-title":"Hematology: basic principles and practice","author":"Kaufman","year":"2000","edition":"3rd edn"},{"key":"2023042012580118700_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.20372","article-title":"von Willebrand's disease and menorrhagia: prevalence, diagnosis, and management","volume":"79","author":"Kujovich","year":"2005","journal-title":"Am J Hematol"},{"key":"2023042012580118700_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-2516.2001.00500.x","article-title":"High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A","volume":"7","author":"Leissinger","year":"2001","journal-title":"Haemophilia"},{"key":"2023042012580118700_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.mph.0000173175.95152.95","article-title":"Oral contraceptives and DDAVP nasal spray: patterns of use in managing vWD-associated menorrhagia: a single-institution study","volume":"27","author":"Amesse","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"2023042012580118700_bib16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1055\/s-0038-1650645","article-title":"Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A","volume":"76","author":"Rodeghiero","year":"1996","journal-title":"Thromb Haemost"},{"key":"2023042012580118700_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.seminhematol.2004.11.002","article-title":"von Willebrand disease and women's health","volume":"42","author":"Lee","year":"2005","journal-title":"Semin Hematol"},{"key":"2023042012580118700_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2005.05511.x","article-title":"The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults","volume":"130","author":"Harrison","year":"2005","journal-title":"Br J Haematol"},{"key":"2023042012580118700_bib19","first-page":"670","article-title":"Evaluation of the PFA-100 system for monitoring desmopressin therapy in patients with type 1 von Willebrand's disease","volume":"87","author":"Franchini","year":"2002","journal-title":"Haematologica"},{"key":"2023042012580118700_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/01.mph.0000168728.49519.4a","article-title":"DDAVP-induced hyponatremia in young children","volume":"27","author":"Das","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"2023042012580118700_bib21","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(89)90915-X","article-title":"Desmopressin and thrombosis","volume":"2","author":"Mannucci","year":"1989","journal-title":"Lancet"},{"key":"2023042012580118700_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11239-006-5732-0","article-title":"Arterial and venous thrombosis in patients with von Willebrand's disease: a critical review of the literature","volume":"21","author":"Girolami","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"2023042012580118700_bib23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1055\/s-0037-1614196","article-title":"Worsening of thrombotic thromboctyopenic purpura symptoms associated with desmopressin administration","volume":"92","author":"Overman","year":"2004","journal-title":"Thromb Haemost"},{"key":"2023042012580118700_bib24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/(SICI)1096-8652(199602)51:2<158::AID-AJH11>3.0.CO;2-E","article-title":"1-Desamino-8-arginine-vasopressin corrects the hemostatic defects in type 2B von Willebrand's disease","volume":"51","author":"McKeown","year":"1996","journal-title":"Am J Hematol"},{"key":"2023042012580118700_bib25","first-page":"1260","article-title":"DDAVP (desmopressin; 1-deamino-cys-8-D-arginine-vasopressin) treatment in children with haemophilia B","volume":"111","author":"Ehl","year":"2000","journal-title":"Br J Haematol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/83\/977\/159\/50023161\/postgradmedj-83-159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/83\/977\/159\/50023161\/postgradmedj-83-159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T14:25:42Z","timestamp":1682000742000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/83\/977\/159\/7045332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,1]]},"references-count":25,"journal-issue":{"issue":"977","published-online":{"date-parts":[[2007,3,7]]},"published-print":{"date-parts":[[2007,3,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2006.052118","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2007,3]]},"published":{"date-parts":[[2007,3,1]]}}}